Asset Sadhu
Funds/Mid Cap Fund/Tata Mid Cap Fund

Tata Mid Cap Fund

Tata Mutual Fund·Mid Cap Fund·vs Nifty Midcap 150 TRI

The fund is heavily tilted toward financials and pharmaceuticals, betting on India's credit growth and domestic consumption recovery. The manager significantly increased conviction in infrastructure plays, notably BHEL, while building defensive cash positions through repo holdings—signaling caution despite maintaining nearly 94% equity exposure. The concentrated top-10 structure and selective exits suggest a quality-focused approach navigating near-term volatility in midcaps.

Portfolio analysis · April 2026

PlanNAV1M3M6M1Y3Y CAGR5Y CAGR
Primary₹441.5657+2.70%-0.47%-1.37%+8.36%+20.08%+17.42%
Returns above 1Y are CAGR. Direct plan rows highlighted. NAV from AMFI.
Holdings
62
Top 5 Weight
14.75%
Top 10 Weight
27.79%
Active Share
Large Cap
8.90%
Gini
0.260
Holdings: 6665+2 added3 removed24 weight shifts ≥ 0.1%
StockWeight
(A) TREPS2.01%
B) REPO2.44%
#Holding% to NAV
1
MANKIND PHARMA LTD
INE634S01028
3.21%
2
FEDERAL BANK LTD
INE171A01029
3.07%
3
BHARAT HEAVY ELECTRICALS LTD
INE257A01026
2.90%
4
INDIAN BANK
INE562A01011
2.79%
5
INDUSIND BANK LTD
INE095A01012
2.78%
6
AU SMALL FINANCE BANK LTD
INE949L01017
2.72%
7
MAX FINANCIAL SERVICES LTD
INE180A01020
2.69%
8
UPL LTD
INE628A01036
2.63%
9
GLENMARK PHARMACEUTICALS LTD
INE935A01035
2.58%
10
B) REPO
2.44%
11
MARICO LTD
INE196A01026
2.42%
12
INDUS TOWERS LTD
INE121J01017
2.27%
13
ONE 97 COMMUNICATIONS LTD
INE982J01020
2.15%
14
MPHASIS LTD
INE356A01018
2.04%
15
(A) TREPS
2.01%
16
L&T FINANCE LTD
INE498L01015
2.00%
17
UNO MINDA LTD
INE405E01023
1.99%
18
BSE LTD
INE118H01025
1.95%
19
CASH / NET CURRENT ASSET
1.92%
20
BHARTI HEXACOM LTD
INE343G01021
1.90%
Banks12.2%
Pharmaceuticals & Biotechnology9.0%
Auto Components7.2%
Insurance4.6%
Finance4.4%
Electrical Equipment4.3%
Telecom - Services4.2%
Fertilizers & Agrochemicals4.0%
Agricultural Food & other Products4.0%
IT - Software4.0%

Top 10 sectors by % to NAV. Excludes derivatives.